# OnCo record apg-157 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/apg-157/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "apg-157" ;
  schema:name "APG-157"@en ;
  schema:description "APG-157 is an experimental oral immunomodulator from Aveta Biomics, in phase 3 trials for locally advanced head and neck squamous cell carcinoma, recurrent high-grade glioma / glioblastoma and oral dysplasia."@en ;
  schema:url <https://onco.cc/drugs/apg-157/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://avetabiomics.com/pipeline>, <https://avetabiomics.com/science>, <https://clinicaltrials.gov/study/NCT07667296>, <https://clinicaltrials.gov/search?intr=APG-157> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral immunomodulator (soft hydrogel pastille dissolved in the mouth)" ;
  onco:cancers <https://onco.cc/cancers/oropharyngeal-cancer/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/oral-cavity-cancer/> ;
  onco:targets <https://onco.cc/targets/stat3/> ;
  onco:companies <https://onco.cc/companies/aveta-biomics/> ;
  onco:trials <https://onco.cc/trials/nct07667296/>, <https://onco.cc/trials/nct05312710/>, <https://onco.cc/trials/nct06011109/>, <https://onco.cc/trials/nct05865028/> .